1. Structural Determinants of Agonist Efficacy at the Glutamate Binding Site ofN-Methyl-d-Aspartate Receptors
- Author
-
Nami Tajima, Kevin K. Ogden, Riley E. Perszyk, Katie M. Vance, Stephen F. Traynelis, Rasmus P. Clausen, Hiro Furukawa, Rune Risgaard, Lars N. Jorgensen, and Kasper B. Hansen
- Subjects
Agonist ,medicine.drug_class ,Glycine ,Glutamic Acid ,AMPA receptor ,Pharmacology ,Receptors, N-Methyl-D-Aspartate ,Partial agonist ,Xenopus laevis ,chemistry.chemical_compound ,Receptors, Kainic Acid ,Excitatory Amino Acid Agonists ,medicine ,Animals ,Humans ,Inverse agonist ,Excitatory Amino Acid Agonist ,alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid ,Cells, Cultured ,Binding Sites ,Glutamate binding ,Articles ,Protein Structure, Tertiary ,Protein Subunits ,HEK293 Cells ,chemistry ,Molecular Medicine ,NMDA receptor ,Female ,Endogenous agonist - Abstract
N-methyl-d-aspartate (NMDA) receptors are ligand-gated ion channels assembled from GluN1 and GluN2 subunits. We used a series of N-hydroxypyrazole-5-glycine (NHP5G) partial agonists at the GluN2 glutamate binding site as tools to study activation of GluN1/GluN2A and GluN1/GluN2D NMDA receptor subtypes. Using two-electrode voltage-clamp electrophysiology, fast-application patch-clamp, and single-channel recordings, we show that propyl- and ethyl-substituted NHP5G agonists have a broad range of agonist efficacies relative to the full agonist glutamate (
- Published
- 2013
- Full Text
- View/download PDF